| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.072 | 13.539 | 14.982 | 18.751 | 19.493 | 9.810 | 19.063 | 20.572 | 21.680 | 28.921 |
| Total Income - EUR | 4.072 | 13.539 | 14.982 | 18.751 | 19.493 | 9.826 | 21.019 | 20.572 | 21.680 | 28.963 |
| Total Expenses - EUR | 3.800 | 11.873 | 11.964 | 10.892 | 15.637 | 8.931 | 17.918 | 15.177 | 19.931 | 19.501 |
| Gross Profit/Loss - EUR | 273 | 1.666 | 3.018 | 7.859 | 3.856 | 895 | 3.101 | 5.395 | 1.749 | 9.462 |
| Net Profit/Loss - EUR | 150 | 1.395 | 2.568 | 7.296 | 3.270 | 731 | 2.640 | 4.846 | 1.564 | 8.175 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Vb Studiodent Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.046 | 3.217 | 2.388 | 9.319 | 7.338 | 5.433 | 4.241 | 3.239 | 2.218 | 16.221 |
| Current Assets | 16 | 194 | 906 | 1.903 | 2.587 | 3.540 | 2.395 | 2.070 | 7.485 | 5.936 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 42 | 0 | 0 | 689 | 5.513 | 686 |
| Cash | 16 | 194 | 906 | 1.903 | 2.545 | 3.540 | 2.395 | 1.381 | 1.972 | 5.250 |
| Shareholders Funds | -3.973 | -2.538 | 74 | 7.369 | 3.312 | 3.980 | 6.532 | 4.894 | 6.444 | 14.583 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.036 | 5.949 | 3.221 | 3.854 | 6.613 | 4.993 | 104 | 415 | 3.259 | 7.574 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Vb Studiodent Srl